ALBUMINAR Side Effects

7028855-5 | Cardiac Failure
on Aug 20, 2010 Male patient from UNITED STATES , weighting 172.6 lb, was diagnosed with plasmapheresis and was treated with Albuminar (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure. Albuminar dosage: Intravenous (not Otherwise Specified). During the same period patient was treated with ATORVASTATIN (ATORVASTATIN) (View Atorvastatin (atorvastatin) Review and Atorvastatin (atorvastatin) Label ), RAPAMUNE (View Rapamune Review and Rapamune Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), PROGRAF (View Prograf Review and Prograf Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), MYCOPHENOLATE (CELLCEPT) (MYCOPHENOLATE MOFETIL) (View Mycophenolate (cellcept) (mycophenolate Mofetil) Review and Mycophenolate (cellcept) (mycophenolate Mofetil) Label ).

7028666-0 | Cardiac Failure, Complications Of Transplanted Heart
Patient was taking Albuminar (View Usage). Patient had the following side effects: cardiac failure, complications of transplanted heart on Sep 15, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 172.6 lb, was diagnosed with plasmapheresis and. Albuminar dosage: (intravenous (not Otherwise Specified)) ; (intravenous (not Otherwise Specified)). During the same period patient was treated with ATORVASTATIN (ATORVASTATIN) (View Atorvastatin (atorvastatin) Review and Atorvastatin (atorvastatin) Label ), RAPAMUNE (View Rapamune Review and Rapamune Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), PROGRAF (View Prograf Review and Prograf Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ).

6486510-4 | Airway Peak Pressure Increased, Anaphylactic Reaction, Flushing, Respiratory Failure, Shock
Adverse event was reported on Nov 11, 2009 by a Male patient taking Albuminar (View Usage) (Dosage: 750 Ml, 750 Ml Intravenous Drip) was diagnosed with haemorrhage, volume blood decreased and. Location: JAPAN , 59 years of age, After Albuminar was administered, patient had the following side effects: airway peak pressure increased, anaphylactic reaction, flushing, respiratory failure, shock. During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), EPHEDRINE SUL CAP (View Ephedrine Sul Cap Review and Ephedrine Sul Cap Label ), ULTIVA (View Ultiva Review and Ultiva Label ), RED BLOOD CELLS (View Red Blood Cells Review and Red Blood Cells Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), PLASMA (View Plasma Review and Plasma Label ).

5468050-4 | Anaphylactic Shock, Capillary Permeability Increased, Flushing, Haemorrhage, Hypovolaemia, Oedema Peripheral, Oxygen Saturation Abnormal, Pulmonary Congestion
on May 07, 2004 Male patient from JAPAN , 59 years of age, was diagnosed with coronary artery bypass (What is coronary artery bypass?) and was treated with Albuminar (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock, capillary permeability increased, flushing, haemorrhage, hypovolaemia, oedema peripheral, oxygen saturation abnormal, pulmonary congestion. Albuminar dosage: 250 Ml Daily Iv. During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ), ROXATIDINE ACETATE HCL (View Roxatidine Acetate Hcl Review and Roxatidine Acetate Hcl Label ), PROPOFOL (View Propofol Review and Propofol Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), KETAMINE HCL (View Ketamine Hcl Review and Ketamine Hcl Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ).


5326588-4 | Antinuclear Antibody Positive, Crohn's Disease, Hepatic Failure, Hepatitis, Hepatitis C Antibody Positive, Laboratory Test Abnormal
on Apr 17, 2007 Female patient from UNITED STATES , child 8 years of age, weighting 49.60 lb, was diagnosed with hypoalbuminaemia, kawasaki's disease and was treated with Albuminar (View Usage). Patient had the following side effects: antinuclear antibody positive, crohn's disease (What is crohn's disease?), hepatic failure, hepatitis (What is hepatitis?), hepatitis c antibody positive, laboratory test abnormal. Albuminar dosage: Iv. During the same period patient was treated with CARIMUNE (8 G Daily Iv) (View Carimune Review and Carimune Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

5326588-4 | Antinuclear Antibody Positive, Crohn's Disease, Hepatic Failure, Hepatitis, Hepatitis C Antibody Positive, Laboratory Test Abnormal
Patient was taking Albuminar (View Usage). After Albuminar was administered, patient had the following side effects: antinuclear antibody positive, crohn's disease (What is crohn's disease?), hepatic failure, hepatitis (What is hepatitis?), hepatitis c antibody positive, laboratory test abnormal on Apr 17, 2007 from UNITED STATES Additional patient health information: Female patient , child 8 years of age, weighting 49.60 lb, was diagnosed with hypoalbuminaemia, kawasaki's disease and. Albuminar dosage: Iv. During the same period patient was treated with CARIMUNE (8 G Daily Iv) (View Carimune Review and Carimune Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

5143101-5 | Blood Pressure Decreased, Infusion Related Reaction, Procedural Complication
Adverse event was reported on Oct 31, 2006 by a Male patient taking Albuminar (View Usage) (Dosage: 50 Ml Once Hemodialysis) was diagnosed with hypotension, hypovolaemia and. Location: UNITED STATES , 78 years of age, weighting 109.8 lb, Patient experienced the following unwanted or unexpected effects: blood pressure decreased, infusion related reaction, procedural complication. During the same period patient was treated with NPH INSULIN (View Nph Insulin Review and Nph Insulin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ).